Roche investing $240 million in Colombia over five years - country general manager
Reuters
Published Nov 16, 2023 16:59
Updated Nov 16, 2023 17:16
By Luis Jaime Acosta
BOGOTA (Reuters) -Swiss drugs and diagnostics maker Roche is investing $240 million in Colombia over five years as part of its plan to consolidate its presence in the country, a high-ranking executive said on Thursday.
The company invested $40 million in 2023 with the inauguration of a new distribution center on the outskirts of Bogota, said Marieli Alfonzo, Roche's general manager in Colombia.
"This investment of $240 million dollars is our commitment for the present and coming years," Alfonzo said in an interview.
Roche has a presence in Colombia with its diagnostic and pharmaceutical divisions, including work on oncology, orphan diseases, neurology and ophthalmology.
"Colombia is a super important country (for Roche), within Latin America it is among the three most important taking into account the population and the health system," Alfonzo said in an interview.
The company delivered 731,000 treatments and performed 168 million diagnostic tests in Colombia last year, Alfonzo said.
The investments show Roche's confidence in the country and will guarantee quality, safety and effectiveness for patients, as well as allowing the company to increase its number of employees in Colombia to 550, from 470, she added.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.